<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes (IBMFS) are at increased risk of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), possibly related to cell cycle dysregulation </plain></SENT>
<SENT sid="1" pm="."><plain>In a cross-sectional analysis of bone marrow from 77 IBMFS, 71 <z:hpo ids='HP_0003745'>sporadic</z:hpo> conditions (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>) and 22 <z:mpath ids='MPATH_458'>normal</z:mpath> controls we found overexpression of p53 in IBMFS, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; of Ki-67 in IBMFS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>; and of survivin in IBMFS compared with <z:hpo ids='HP_0000001'>all</z:hpo> other groups </plain></SENT>
<SENT sid="2" pm="."><plain>The patterns of expression of cell cycle markers in IBMFS are thus distinct </plain></SENT>
<SENT sid="3" pm="."><plain>Longitudinal studies will determine the diagnostic and prognostic significance of these findings </plain></SENT>
</text></document>